Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Steven W. Yancey

Mepolizumab Improves Patient Outcomes and Reduces Exacerbations in Severe Asthma Patients With Comorbid Upper Airways Disease

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy of 100 Mg SC Mepolizumab for Severe Eosinophilic Asthma (SEA) Across Blood Eosinophil Counts: Meta-Analysis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy of 100 Mg SC Mepolizumab for Severe Eosinophilic Asthma (SEA) Across Body Weight: Meta-Analysis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Mepolizumab Reduces Exacerbations in Patients With Severe Eosinophilic Asthma, Irrespective of Body Weight/Body Mass Index: Meta-Analysis of MENSA and MUSCA

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics
Pharmacology
2016English

Pharmacogenetic Investigation of Efficacy Response to Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis

Rheumatology International
RheumatologyAllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy